Jaeger U - Search Results

1

B-cell lymphoma and arterial esophageal bleeding.

Feierl E, Dejaco C, Heintel D, Wagner A, Chatwani S, Stelzhammer R, Hammer J, Jaeger U, End A. Feierl E, et al. Among authors: jaeger u. Gastrointest Endosc. 2003 Mar;57(3):387-8. doi: 10.1067/mge.2003.94. Gastrointest Endosc. 2003. PMID: 12612526 No abstract available.

2

Association of CD38 antigen expression with other prognostic parameters in early stages of chronic lymphocytic leukemia.

Heintel D, Schwarzinger I, Chizzali-Bonfadin C, Thalhammer R, Schwarzmeier J, Fritzer-Szekeres M, Weltermann A, Simonitsch I, Lechner K, Jaeger U. Heintel D, et al. Among authors: jaeger u. Leuk Lymphoma. 2001 Nov-Dec;42(6):1315-21. doi: 10.3109/10428190109097758. Leuk Lymphoma. 2001. PMID: 11911414

3

Variable prognostic value of FLT3 internal tandem duplications in patients with de novo AML and a normal karyotype, t(15;17), t(8;21) or inv(16).

Kainz B, Heintel D, Marculescu R, Schwarzinger I, Sperr W, Le T, Weltermann A, Fonatsch C, Haas OA, Mannhalter C, Lechner K, Jaeger U. Kainz B, et al. Among authors: jaeger u. Hematol J. 2002;3(6):283-9. doi: 10.1038/sj.thj.6200196. Hematol J. 2002. PMID: 12522450

4

Burkitt lymphoma following splenic marginal zone lymphoma. evidence for two independent B-cell clones.

Heintel D, Streubel B, Welzel N, Le T, Schwarzinger I, Haas OA, Simonitsch I, Lechner K, Jaeger U. Heintel D, et al. Among authors: jaeger u. Cancer Genet Cytogenet. 2003 Feb;141(1):86-8. doi: 10.1016/s0165-4608(02)00724-0. Cancer Genet Cytogenet. 2003. PMID: 12581905

5

Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders.

Kornauth C, Pemovska T, Vladimer GI, Bayer G, Bergmann M, Eder S, Eichner R, Erl M, Esterbauer H, Exner R, Felsleitner-Hauer V, Forte M, Gaiger A, Geissler K, Greinix HT, Gstöttner W, Hacker M, Hartmann BL, Hauswirth AW, Heinemann T, Heintel D, Hoda MA, Hopfinger G, Jaeger U, Kazianka L, Kenner L, Kiesewetter B, Krall N, Krajnik G, Kubicek S, Le T, Lubowitzki S, Mayerhoefer ME, Menschel E, Merkel O, Miura K, Müllauer L, Neumeister P, Noesslinger T, Ocko K, Öhler L, Panny M, Pichler A, Porpaczy E, Prager GW, Raderer M, Ristl R, Ruckser R, Salamon J, Schiefer AI, Schmolke AS, Schwarzinger I, Selzer E, Sillaber C, Skrabs C, Sperr WR, Srndic I, Thalhammer R, Valent P, van der Kouwe E, Vanura K, Vogt S, Waldstein C, Wolf D, Zielinski CC, Zojer N, Simonitsch-Klupp I, Superti-Furga G, Snijder B, Staber PB. Kornauth C, et al. Among authors: jaeger u. Cancer Discov. 2022 Feb;12(2):372-387. doi: 10.1158/2159-8290.CD-21-0538. Epub 2021 Oct 11. Cancer Discov. 2022. PMID: 34635570 Free PMC article.

6

Templated nucleotide addition and immunoglobulin JH-gene utilization in t(11;14) junctions: implications for the mechanism of translocation and the origin of mantle cell lymphoma.

Welzel N, Le T, Marculescu R, Mitterbauer G, Chott A, Pott C, Kneba M, Du MQ, Kusec R, Drach J, Raderer M, Mannhalter C, Lechner K, Nadel B, Jaeger U. Welzel N, et al. Among authors: jaeger u. Cancer Res. 2001 Feb 15;61(4):1629-36. Cancer Res. 2001. PMID: 11245476

7

Long-term clinical and molecular remission after allogeneic stem cell transplantation (SCT) in patients with poor prognosis non-Hodgkin's lymphoma.

Mitterbauer M, Neumeister P, Kalhs P, Brugger S, Fischer G, Dieckmann K, Hoecker P, Hinterberger W, Linkesch W, Simonitsch I, Jaeger U, Lechner K, Mannhalter C, Mitterbauer G, Greinix HT. Mitterbauer M, et al. Among authors: jaeger u. Leukemia. 2001 Apr;15(4):635-41. doi: 10.1038/sj.leu.2402053. Leukemia. 2001. PMID: 11368367

8

Positron emission tomography with [18F]2-fluoro-D-2-deoxyglucose (FDG-PET) predicts relapse of malignant lymphoma after high-dose therapy with stem cell transplantation.

Becherer A, Mitterbauer M, Jaeger U, Kalhs P, Greinix HT, Karanikas G, Pötzi C, Raderer M, Dudczak R, Kletter K. Becherer A, et al. Among authors: jaeger u. Leukemia. 2002 Feb;16(2):260-7. doi: 10.1038/sj.leu.2402342. Leukemia. 2002. PMID: 11840293

9

Cyclin D3 is a predictive and prognostic factor in diffuse large B-cell lymphoma.

Filipits M, Jaeger U, Pohl G, Stranzl T, Simonitsch I, Kaider A, Skrabs C, Pirker R. Filipits M, et al. Among authors: jaeger u. Clin Cancer Res. 2002 Mar;8(3):729-33. Clin Cancer Res. 2002. PMID: 11895902

10

Prognostic significance of molecular staging by PCR-amplification of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma (DLBCL).

Mitterbauer-Hohendanner G, Mannhalter C, Winkler K, Mitterbauer M, Skrabs C, Chott A, Simonitsch-Klupp I, Gleiss A, Lechner K, Jaeger U. Mitterbauer-Hohendanner G, et al. Among authors: jaeger u. Leukemia. 2004 Jun;18(6):1102-7. doi: 10.1038/sj.leu.2403376. Leukemia. 2004. PMID: 15085149

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

244 results

Search Page

Filters